Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
30,07 USD | +2,59% | +2,28% | +3,90% |
Vakgebied
Aantal werknemers: 652
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Treatment of Central Nervous System Diseases
100,0
%
| 667 | 100,0 % | 608 | 100,0 % | -8,95% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 667 | 100,0 % | 608 | 100,0 % | -8,95% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jack Khattar
FOU | Founder | 62 | 30-03-05 |
Timothy Dec
DFI | Director of Finance/CFO | 66 | 23-08-21 |
Frank Mottola
CTO | Chief Tech/Sci/R&D Officer | 52 | 01-01-05 |
Jonathan Rubin
CTO | Chief Tech/Sci/R&D Officer | 62 | 01-02-20 |
Chief Tech/Sci/R&D Officer | 66 | 30-03-05 | |
Compliance Officer | 61 | 01-01-12 | |
Taylor Raiford
SAM | Sales & Marketing | - | 01-01-15 |
Todd Horich
SAM | Sales & Marketing | - | 31-05-18 |
Corporate Officer/Principal | - | 01-07-15 | |
Tami Martin
LAW | General Counsel | 68 | 01-01-08 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Georges Gemayel
BRD | Director/Board Member | 64 | 23-03-15 |
Charles Newhall
CHM | Chairman | 79 | 30-03-05 |
John Siebert
BRD | Director/Board Member | 84 | 01-01-11 |
Frederick Hudson
BRD | Director/Board Member | 78 | 16-11-10 |
Carrolee Barlow
BRD | Director/Board Member | 60 | 27-06-18 |
Jack Khattar
FOU | Founder | 62 | 30-03-05 |
Bethany Sensenig
BRD | Director/Board Member | 48 | 21-08-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 54 734 956 | 51 934 710 ( 94,88 %) | 0 | 94,88 % |
Bedrijfsgegevens
Supernus Pharmaceuticals, Inc.
9715 Key West Avenue
20850, Rockville
+301 838 2500
http://www.supernus.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,90% | 1,65 mld. | |
+5,31% | 70,44 mld. | |
+10,97% | 8,94 mld. | |
-16,83% | 4,75 mld. | |
+43,48% | 4,5 mld. | |
+3,20% | 3,85 mld. | |
+18,82% | 2,38 mld. | |
-21,36% | 2,34 mld. | |
-29,67% | 2,2 mld. | |
+8,38% | 1,96 mld. |
- Beurs
- Aandelen
- Koers SUPN
- Onderneming Supernus Pharmaceuticals, Inc.